| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2021 | Nov 23, 2021 | Oruka Therapeutics, Inc. | S.V.P., General Counsel | Buy | 95.0 | +50,000 | 5154.64% | ✗ | $113.2K |
| Apr 4, 2017 | Apr 5, 2017 | Oruka Therapeutics, Inc. | S.V.P., General Counsel | Sell | 46.3 | -418 | -2.33% | ✓ | $1K |
| Feb 28, 2017 | Mar 1, 2017 | Oruka Therapeutics, Inc. | S.V.P., General Counsel | Sell | 46.3 | -465 | -2.53% | ✓ | $1.2K |
| Sep 20, 2016 | Sep 21, 2016 | Oruka Therapeutics, Inc. | S.V.P., General Counsel | Sell | 37.5 | -1,185 | -6.05% | ✓ | $3.4K |
| Apr 5, 2016 | Apr 6, 2016 | Oruka Therapeutics, Inc. | S.V.P., General Counsel | Sell | 50.0 | -366 | -1.83% | ✓ | $1.3K |
| Mar 1, 2016 | Mar 2, 2016 | Oruka Therapeutics, Inc. | S.V.P., General Counsel | Sell | 46.3 | -458 | -2.24% | ✓ | $1.6K |
| Sep 18, 2015 | Sep 21, 2015 | Oruka Therapeutics, Inc. | S.V.P., General Counsel | Sell | 37.5 | -1,129 | -5.24% | ✓ | $7.1K |